JPWO2022107755A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022107755A5 JPWO2022107755A5 JP2022563761A JP2022563761A JPWO2022107755A5 JP WO2022107755 A5 JPWO2022107755 A5 JP WO2022107755A5 JP 2022563761 A JP2022563761 A JP 2022563761A JP 2022563761 A JP2022563761 A JP 2022563761A JP WO2022107755 A5 JPWO2022107755 A5 JP WO2022107755A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyloxy
- hydrogen atom
- acridinium salt
- formula
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020191118 | 2020-11-17 | ||
| JP2020191118 | 2020-11-17 | ||
| PCT/JP2021/042049 WO2022107755A1 (ja) | 2020-11-17 | 2021-11-16 | 新規アクリジニウム塩およびその製造方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2022107755A1 JPWO2022107755A1 (https=) | 2022-05-27 |
| JPWO2022107755A5 true JPWO2022107755A5 (https=) | 2024-09-10 |
| JP7685522B2 JP7685522B2 (ja) | 2025-05-29 |
Family
ID=81707996
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022563761A Active JP7685522B2 (ja) | 2020-11-17 | 2021-11-16 | 新規アクリジニウム塩およびその製造方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230278960A1 (https=) |
| EP (1) | EP4249077A4 (https=) |
| JP (1) | JP7685522B2 (https=) |
| CN (1) | CN116783167A (https=) |
| AR (1) | AR124071A1 (https=) |
| WO (1) | WO2022107755A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250129029A1 (en) * | 2021-09-06 | 2025-04-24 | Osaka University | Acridine compound |
| CN116082361B (zh) * | 2023-04-11 | 2023-06-13 | 和鼎（南京）医药技术有限公司 | 一种制备玛巴洛沙韦中间体和玛巴洛沙韦的方法 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI2320908T1 (sl) | 2008-07-25 | 2014-05-30 | Viiv Healthcare Company | Predzdravila dolutegravirja |
| WO2010011819A1 (en) | 2008-07-25 | 2010-01-28 | Smithkline Beecham Corporation | Chemical compounds |
| CA2744019C (en) | 2008-12-11 | 2017-03-14 | Shionogi & Co., Ltd. | Synthesis of carbamoylpyridone hiv integrase inhibitors and intermediates |
| KR101682058B1 (ko) | 2008-12-11 | 2016-12-02 | 비이브 헬쓰케어 컴퍼니 | 카르바모일피리돈 ｈｉｖ 인테그라제 억제제를 위한 제조방법 및 중간체 |
| TWI518084B (zh) | 2009-03-26 | 2016-01-21 | 鹽野義製藥股份有限公司 | 哌喃酮與吡啶酮衍生物之製造方法 |
| US20140011995A1 (en) | 2010-08-05 | 2014-01-09 | Yukihito Sumino | Process for Preparing Compound Having HIV Integrase Inhibitory Activity |
| WO2014128545A2 (en) | 2013-02-19 | 2014-08-28 | Aurobindo Pharma Limited | An improved process for the preparation of dolutegravir |
| EP3022209B1 (en) | 2013-07-17 | 2018-03-07 | ratiopharm GmbH | Dolutegravir potassium salt |
| WO2015019310A1 (en) | 2013-08-07 | 2015-02-12 | Mylan Laboratories Ltd | Process for the preparation of dolute-gravir and intermediates thereof |
| US9856271B2 (en) | 2014-01-21 | 2018-01-02 | Laurus Labs Limited | Process for the preparation of dolutegravir and pharmaceutically acceptable salts thereof |
| ZA201503540B (en) | 2014-05-20 | 2016-10-26 | Cipla Ltd | Process for preparing polycyclic carbamoyl pyridone derivatives |
| WO2016092527A1 (en) | 2014-12-12 | 2016-06-16 | Sun Pharmaceutical Industries Limited | A process for the preparation of dolutegravir |
| US10730888B2 (en) | 2015-02-06 | 2020-08-04 | Mylan Laboratories Limited | Process for the preparation of dolutegravir |
| BR112017022550B1 (pt) | 2015-04-28 | 2021-02-23 | Shionogi & Co., Ltd | derivados policíclicos de piridona substituída |
| WO2016196816A1 (en) * | 2015-06-03 | 2016-12-08 | The University Of North Carolina At Chapel Hill | Photoredox-catalyzed direct c-h functionalization of arenes |
| AU2016374416A1 (en) | 2015-12-15 | 2018-06-14 | Shionogi & Co., Ltd. | Medicine for treating influenza characterized by comprising combination of cap-dependent endonuclease inhibitor with anti-influenza drug |
| JP6924839B2 (ja) * | 2017-10-06 | 2021-08-25 | 塩野義製薬株式会社 | 置換された多環性ピリドン誘導体の立体選択的な製造方法 |
| WO2020176804A1 (en) * | 2019-02-28 | 2020-09-03 | The University Of North Carolina At Chapel Hill | Direct aromatic carbon-oxygen and carbon-hydrogen bond functionalization via organic photoredox catalyst |
-
2021
- 2021-11-16 JP JP2022563761A patent/JP7685522B2/ja active Active
- 2021-11-16 AR ARP210103161A patent/AR124071A1/es not_active Application Discontinuation
- 2021-11-16 EP EP21894629.1A patent/EP4249077A4/en active Pending
- 2021-11-16 WO PCT/JP2021/042049 patent/WO2022107755A1/ja not_active Ceased
- 2021-11-16 CN CN202180077224.0A patent/CN116783167A/zh active Pending
-
2023
- 2023-05-11 US US18/196,255 patent/US20230278960A1/en active Pending